Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,753
datasets available to search
ShareScore release 0.9.0
Dataset results
2,753 results for “NSCLC”
Liquid Biopsy for Detection of Driver Mutation in NSCLC
ClinicalTrials.gov study NCT02778854. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade
ClinicalTrials.gov study NCT04340882. IPD Sharing: NO. Countries: 1. Publications: 1.
TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00563784. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01820754. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BATTLE Program: Sorafenib in Patients With NSCLC
ClinicalTrials.gov study NCT00411671. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)
ClinicalTrials.gov study NCT03083041. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery
ClinicalTrials.gov study NCT04026412. IPD Sharing: Not stated. Countries: 27. Publications: 1.
Atezolizumab Plus Bevacizumab in First Line NSCLC Patients
ClinicalTrials.gov study NCT03836066. IPD Sharing: NO. Countries: 1. Publications: 1.
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
ClinicalTrials.gov study NCT02591615. IPD Sharing: NO. Countries: 1. Publications: 50.
Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study
ClinicalTrials.gov study NCT03381274. IPD Sharing: YES. Countries: 3. Publications: 1.
Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC
ClinicalTrials.gov study NCT00280735. IPD Sharing: NO. Countries: 1. Publications: 1.
BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC
ClinicalTrials.gov study NCT00410059. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy
ClinicalTrials.gov study NCT02705820. IPD Sharing: NO. Countries: 1. Publications: 2.
Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial
ClinicalTrials.gov study NCT02045446. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Immune and Genomic Markers in ALK+ NSCLC
ClinicalTrials.gov study NCT04881916. IPD Sharing: YES. Countries: 1. Publications: 1.
Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01026844. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
ClinicalTrials.gov study NCT01355497. IPD Sharing: Not stated. Countries: 1. Publications: 1.
National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC
ClinicalTrials.gov study NCT03982459. IPD Sharing: YES. Countries: 1. Publications: 1.
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00949910. IPD Sharing: Not stated. Countries: 51. Publications: 2.
BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00411632. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.